Nicole Dale

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

Read FDA MedWatch: Adverse Event Reporting at the Centre of Drug Safety
- Pharmacovigilance & Safety
- FDA
- Global Regulatory Affairs
- Pharmacovigilance
- Adverse Event Monitoring
- Adverse Events
- Health Surveillance
- Post-market
- Pharma Regulation
- Regulatory Warning Letters
- Pharma Policy
- Patient Care
- Medical Devices
- Medical Imaging
- Diagnostics
- Biologics
- Documentation
- Clinical Research Organisations
- Clinical Data
- Drug Recalls
- Regulatory Consultation
- Pharmaceutical Manufacturing
- Quality
- Quality Assurance
- Pharmaceutical Compliance
- Medical Governance
FDA MedWatch: Adverse Event Reporting at the Centre of Drug Safety
Read Pharmaceutical Quality Control Powering Supply Resilience
- Quality Assurance & cGMP
- Quality
- Data Quality
- ALCOA
- Quality Assurance
- Laboratory Quality
- Process Development
- Continuous Manufacturing
- Cold Chain
- Analytical Monitoring
- AI & Machine Learning
- AI and Automation
- AI Drug Development
- Biopharmaceutical Manufacturing
- Contract Manufacturing (CDMO/CMO)
- Decentralised Manufacturing
- Data Management
- Good Manufacturing Practice
- Manufacturing Technology
- Pharmaceutical Manufacturing
- Sterile Manufacturing
- Data Analysis
- Data Cleaning & Preparation
- Data Integrity
- Site Inspection
- Peptides and Obesity Treatments
- Pharma Supply Chains
- Supply Network Strategy
- Biologics
- Small Molecules
- Next-gen Modalities
- Antibody Drug Conjugates
- Documentation
- Trial Operations & CMC
- CMC
- Pharmaceutical Compliance
- Pharma Policy
- Drug Production
- Pharmacovigilance & Safety
- Labelling and Packaging
- Technical Operations
Pharmaceutical Quality Control Powering Supply Resilience
Read FDA vs EMA Drug Labelling for Global Medical Safety
- Labelling and Packaging
- Pharmacovigilance & Safety
- Harmonisation Standards
- Pharmacovigilance
- FDA
- European Medicinces Agency
- Global Regulatory Affairs
- Pharma Regulation
- Regulatory Submissions
- Regulatory Consultation
- Regulatory & IP
- Regulatory Warning Letters
- Pharma Policy
- Post-market
- Commercialisation & Medical Affairs
- Commercial Strategy
- Common Technical Document
- Medical Writers
- Clinical Research Organisations
- Clinical Evidence
- Clinical Data
- Digital Ecosystems
- Data Quality
- Data Protection
- Data Integrity
- Real-World Data
- Real-world Evidence
- Pricing and Market Access
- Multinational Trials
- Drug Approval
- Documentation
- Patient Access
- Patient Care
- pharmaceutical industry
- Pharmaceutical Compliance
- Pharma Intelligence
- Adverse Event Monitoring
- Adverse Events
- Health Surveillance
- Patient Registries
- Medical Governance
- Oncology
- Oncology & Radiotherapeutics
- Oversight
- Medtech
- Digital Health
- Digital Health Technology
FDA vs EMA Drug Labelling for Global Medical Safety
Read Pharmaceutical Packaging for Patient Safety
- Pharmaceutical Manufacturing
- Labelling and Packaging
- Safety & Toxicology
- Pharmacovigilance & Safety
- Adverse Events
- Continuous Manufacturing
- Sterile Manufacturing
- Cold Chain
- Patient Care
- Pharma Supply Chains
- Supply Network Strategy
- Manufacturing Technology
- Continuous Improvement
- Pharma Regulation
- Regulatory & IP
- Formulation
- Contract Manufacturing (CDMO/CMO)
- Quality
- Quality Assurance
- Trial Operations & CMC
- Technical Operations
- Sustainability
- Digital Ecosystems
- Data Quality
- Containment
- Good Manufacturing Practice
- Biologics
- Pharmacovigilance
Pharmaceutical Packaging for Patient Safety